Sanctions & Tariff Lookup

Duty calculator › Tariff programs

Section 232: pharmaceuticals

In force · Section 232 of the Trade Expansion Act of 1962 · HTS chapter 99, subchapter III, U.S. note 40

Patented pharmaceutical articles on the ten-digit lines listed in U.S. note 40(c) (a drug under a valid U.S. patent that is listed in the FDA Orange Book or Purple Book, and its active ingredients and key starting materials) are dutiable at 100 percent in total, in place of the column 1 rate, in full effect since September 29, 2026. The total is 15 percent for products of Japan, the European Union, South Korea, Switzerland and Liechtenstein, and nothing is added for products of the United Kingdom, qualifying specialty drugs, companies with both an onshoring plan and a pricing agreement (an onshoring plan alone pays an additional 20 percent), dosage products with a U.S. active ingredient, goods solely for clinical trials or research, generic drugs and other listed articles that are not patented pharmaceutical articles. The headings are mutually exclusive, so the tool reports the lowest rate that fits; give the 10-digit code, because the list is made of 10-digit statistical lines.

An estimate for a person to review, not a customs ruling. Built from 2026 HTS Revision 23 and the USITC Chapter 99 notes (rules version 46ce9712bc246f6d), recalculated on every page view. Default assumptions: no trade-agreement preference claimed, no special use. Antidumping and countervailing duties, quotas and fees are not included. Not affiliated with the USITC, CBP or the USTR.

Common products it adds duty to

None of the 47 products on the duty by product pages picks up a layer from it for the 20 largest origins with default assumptions.

Check any HTS line and origin in the free duty calculator, or ask Claude with the free Sanctions & Tariff Lookup connector (tools duty_stack and compare_origins). Several lines at once: the shipment duty estimate adds up to 200 lines (HTS code, origin, value) into one PDF report with every layer per line.

Questions

What is Section 232: pharmaceuticals?

Patented pharmaceutical articles on the ten-digit lines listed in U.S. note 40(c) (a drug under a valid U.S. patent that is listed in the FDA Orange Book or Purple Book, and its active ingredients and key starting materials) are dutiable at 100 percent in total, in place of the column 1 rate, in full effect since September 29, 2026. The total is 15 percent for products of Japan, the European Union, South Korea, Switzerland and Liechtenstein, and nothing is added for products of the United Kingdom, qualifying specialty drugs, companies with both an onshoring plan and a pricing agreement (an onshoring plan alone pays an additional 20 percent), dosage products with a U.S. active ingredient, goods solely for clinical trials or research, generic drugs and other listed articles that are not patented pharmaceutical articles. The headings are mutually exclusive, so the tool reports the lowest rate that fits; give the 10-digit code, because the list is made of 10-digit statistical lines.

Is Section 232: pharmaceuticals in force?

Yes, under rules version 46ce9712bc246f6d built from 2026 HTS Revision 23. The duty calculator adds it whenever a line and origin fall under it.

Which products does Section 232: pharmaceuticals apply to?

None of the 47 common products on this site's duty pages picks up a layer from it for the 20 largest origins with default assumptions. Check a specific HTS line in the free duty calculator.

Is this a customs ruling?

No. It is an estimate for a person to review. Classification, origin and the duty owed are decided under customs law; confirm them with U.S. Customs and Border Protection or a licensed customs broker. Antidumping and countervailing duties, quotas and fees are not included.

Sources

Other tariff programs

Section 232: passenger vehicles, light trucks and parts · Section 232: medium- and heavy-duty vehicles and parts · Section 232: timber, lumber and wood products · Section 232: semiconductors · Section 232: unmanned aircraft systems · Section 232: steel, aluminum and copper · Section 301: China (2018 action) · Section 301: China (2024 four-year review increases) · Section 301: forced-labor action (60 economies) · Section 301: Brazil · Section 338: Canada · Column 2 duty increases for Russia · IEEPA duties (fentanyl-related and reciprocal tariffs) · Section 122 temporary import surcharge

Found a wrong result? Tell us through the support form with the HTS code and the country.